Ketti Mazzocco

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

N/A

0Author DataRank · unranked

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trial”.

ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trial

The Lancet Oncology(2025)10.1016/s1470-2045(24)00730-7

N/A

0.666DataRank · unranked

84 citations

Giulia Corrao, Mattia Zaffaroni, Maria Giulia Vincini, Chiara Lorubbio, Sara Gandini +21 more

Results of the Italian cross-sectional web-based survey “Nutrition and breast cancer, what would you like to know?” An attempt to collect and respond to patients’ information needs, through social media

Frontiers in Oncology(2024)10.3389/fonc.2024.1436610

N/A

0.269DataRank · unranked

5 citations

Eleonora Pagan, Lucilla Titta, Maria Tieri, Giada Magionesi, Silvia Gallosti +4 more